FAQs
General/Corporate
PLx Pharma was incorporated in Delaware on July 27, 2015.
PLx Pharma’s fiscal year is from January 1 to December 31.
PLx Pharma’s stock is traded as common stock on the NASDAQ Capital Markets under the ticker symbol “PLXP.”
Transfer Agent
The transfer agent and registrar for shares of PLx Pharma’s common stock is VStock Transfer, LLC.
VStock Transfer, LLC
18 Lafayette Pl
Woodmere, NY 11598
Toll-Free: 855-9VSTOCK
Email:
Website:
VStock Transfer is available to assist shareholders with stock transfers, changes of address, and replacement of lost stock certificates.
VStock Transfer, LLC
18 Lafayette Pl
Woodmere, NY 11598
Phone: 212-828-8436
Toll-Free: 855-9VSTOCK
Email:
info@vstocktransfer.com
Website:
https://www.vstocktransfer.com/
No, PLx Pharma does not have a direct stock purchase plan.
Auditor/Legal
PLx Pharma’s auditor is Marcum LLP (New York).
Olshan Frome Wolosky LLP (New York).
Company Inquiries
You’ll find the latest SEC Filings within this link.
You’ll find the Management Team and Board of Directors within these links.
Phone: (973) 409-6541
Fax: (973) 843-6300
Email:
Please contact PLx Pharma’s investor relations department with any investor inquiries.
or
Lisa M. Wilson, In-Site Communications, Inc.
Email: lwilson@insitecony.com
Phone: 212.452.2793
You can receive email updates by signing up to be included on the PLx Pharma’s distribution list.